Selected blood parameters of inflammation (circulating immune complexes, CIC, C-reactive protein, CRP, neutrophil/ lymphocyte ratio and platelet/lymphocyte ratio) in patients with chronic obstructive pulmonary disease (COPD) M. Pilaczynska-Cemel (Bydgoszcz, Poland), R. Golada (Bydgoszcz, Poland), A. Dabrowska (Bydgoszcz, Poland), T. Wandtke (Bydgoszcz, Poland), G. Przybylski (Bydgoszcz, Poland)
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Disease area: Airway diseasesRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Pilaczynska-Cemel (Bydgoszcz, Poland), R. Golada (Bydgoszcz, Poland), A. Dabrowska (Bydgoszcz, Poland), T. Wandtke (Bydgoszcz, Poland), G. Przybylski (Bydgoszcz, Poland). Selected blood parameters of inflammation (circulating immune complexes, CIC, C-reactive protein, CRP, neutrophil/ lymphocyte ratio and platelet/lymphocyte ratio) in patients with chronic obstructive pulmonary disease (COPD). 208
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Source: Eur Respir J 2008; 32: 1451-1457 Year: 2008
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients Source: Eur Respir J 2006; 27: 902-907 Year: 2006
Evaluation of neutrophil lymphocyte ratio and C-reactive protein values in the treatment of acute chronic obstructive pulmonary disease exacerbation according to endotype Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020
Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008
Body composition and plasma levels of inflammatory biomarkers in COPD Source: Eur Respir J 2010; 36: 1027-1033 Year: 2010
The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 363s Year: 2007
High sensivity C reactive protein (HS-CRP) levels mark pulmonary and systemic inflammation in stable COPD Source: Eur Respir J 2006; 28: Suppl. 50, 337s Year: 2006
Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016
Systemic inflammation, blood eosinophils count and lung function in COPD patients Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017
Performance of rapid, bedside whole blood C-reactive protein (CRP) test as a diagnostic test for bacterial infection and pneumonia in patients with acute exacerbation of chronic obstructive pulmonary disease (AE COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007
Systemic inflammation in exacerbated patients with chronic obstructive pulmonary disease (COPD): the role of alterations in leptin/ghrelin ratio and/or leptin/adiponectin ratio Source: Annual Congress 2007 - Biomarkers and assessment of COPD Year: 2007
Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008
C-reactive protein (CRP) as a risk marker in COPD patients with ischaemic heart disease Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008
Antinuclear autoantibodies (ANA) and C-reactive protein (CRP) in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015
Inflammatory mediators CRP, fibrinogen and leukocyte in stable COPD patients Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I Year: 2007
Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity. Source: International Congress 2017 – COPD biomarkers Year: 2017
C-reactive protein (CRP) as a marker of disease severity in community acquired pneumonia patients with sepsis Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012
Is there a relationship between severity of COPD and C-reactive protein (CRP) levels? Source: Eur Respir J 2006; 28: Suppl. 50, 37s Year: 2006
Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012
Stability of blood eosinophilia and neutrophil-to-lymphocyte ratio in COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018